Regeneron Pharmaceuticals Unusual Options Activity For March 20
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NASDAQ:REGN) has seen unusual options activity, with a bullish sentiment from deep-pocketed investors. The activity includes 10 extraordinary options trades, with 60% bullish and 40% bearish sentiment. The focus is on a price band between $900.0 and $1020.0. The company, known for its products in eye disease, cardiovascular disease, cancer, and inflammation, has a current stock price of $966.07, up 0.25%. Analysts have given an average target price of $1137.25, with varying ratings from Outperform to Overweight.
March 20, 2024 | 7:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Regeneron Pharmaceuticals sees unusual options activity with a bullish sentiment, indicating potential upward movement. Analysts have set an average target price of $1137.25, suggesting room for growth.
The unusual options activity, particularly the bullish sentiment among investors, suggests optimism about Regeneron's future performance. This is further supported by the analysts' target price, which is significantly higher than the current stock price. Given the company's strong product portfolio and the current market status, there is a high likelihood of positive short-term price movement.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100